Advertisement
Advertisement
NNNN
Anbio Biotechnology Class A Ordinary Shares
25.24
USDSponsored
-0.56
-2.17%
May 13, 16:00 UTC -4
Closed
After-Market
25.00
-0.23
-0.93%
NNNN Earnings Reports
Positive Surprise Ratio
No Data Available for NNNN
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Anbio Biotechnology Class A Ordinary Shares earnings per share and revenue
On Apr 27, 2026, NNNN reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vor Biopharma Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.78
Actual
-$0.73
Surprise
+7.38%
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.01
Actual
$0.22
Surprise
+2278.22%
Immunic, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.93
Actual
-$1.08
Surprise
-16.03%
Humacyte, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+24.05%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
PDS Biotechnology Corporation Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.13
Surprise
+15.03%
FAQ
What were Anbio Biotechnology Class A Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Anbio Biotechnology Class A Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Anbio Biotechnology Class A Ordinary Shares's Q4 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Anbio Biotechnology Class A Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Anbio Biotechnology Class A Ordinary Shares's next earnings report?
Based on --
analysts, Anbio Biotechnology Class A Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement